Camson Bio Technologies financials and balance sheet

BSE: 538858Pharmaceuticals & Biotechnology

Trading suspended since 6 May 2021

Last traded ₹3.31 on 11 May 2020

5 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Camson Bio Technologies annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in 3 of the 4 years with results on record

Operating and net margin, per cent

  • Operating margin
  • Net margin

The years either side of a change of basis do not compare. From the year to Mar 2016, part of the business was demerged on 21 Sep 2015, and figures before the change include the part that left.

Results for the year to Mar 2019

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue5.0
  2. Materials and goods−15
  3. Employee costs−3.0
  4. Other expenses−3.2
  5. Operating profit−16
  6. Depreciation−7.0
  7. Other income+3.2
  8. One-off items0.0
  9. Finance costs−1.1
  10. Profit before tax−21
  11. Tax−0.6
  12. Net profit−22

What the company owns

  • Plant, investments and other assets₹90 Cr
  • Inventory₹26 Cr
  • Receivables₹15 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Borrowings₹50 Cr
  • Net worth₹45 Cr
  • Other liabilities₹29 Cr
  • Owed to suppliers₹8 Cr

Profit and loss

Standalone, ₹ crore, years to March. No results on record for the year to Mar 2016.Camson Bio Technologies quarterly results

₹ croreMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 7 Jun
Revenue from operations169–10195
153–281921
Materials and goods bought76–2815
Employee costs––653
Other expenses––1973
Operating profit before depreciation16–−170−16
Operating margin9.6%–−167.7%0.2%−329.4%
Materials, % of revenue––23.9%39.9%305.0%
Employee costs, % of revenue––56.3%26.1%59.4%
Other expenses, % of revenue––187.5%33.8%65.0%
Depreciation and amortisation13–777
Operating profit after depreciation3–−25−7−23
Other income6–413
Finance costs4–751
One-off items––––0
Profit before tax5–−27−11−21
2–0–1
Net profit3–−27−11−22
Net margin1.8%–−262.8%−58.1%−440.0%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2015 they do not, so they are left blank.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 7 Jun
45
Share capital30
Reserves15
50
73
13
Total assets131
87
44
Net debt50
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2015, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 7 Jun
Earnings per share−₹9.07−₹3.68−₹7.30
Diluted earnings per share−₹9.07−₹3.68−₹7.30
Book value per share––₹14.92
Market cap at the year end (₹ crore)52.2–20.8

Ratios

Standalone, years to March.

RatioMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 7 Jun
Revenue growth–––86.6%−74.2%
Return on equity––––−48.9%
Return on capital employed––––−24.7%
Interest cover0.7––––
Debt to equity––––1.11
Receivable days––––1,134
Inventory days––––622
Payable days––––183
Cash conversion cycle, days––––1,574
Working capital days––––687
Asset turnover––––0.04
Assets per rupee of net worth––––2.93
Sales per rupee of plant––––0.06
Interest cover is left blank for the years to Mar 2017, Mar 2018 and Mar 2019: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2015, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2019.

Return on assets, latest year
−16.7%
Measure5 years3 years
Operating margin, average−121.8%−165.6%
Net margin, average−189.8%−253.6%

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Altman Z-scorePublished threshold 1.81––––−0.43
Effective tax ratePublished threshold 17.16 per cent38.94––––
A threshold marked as ours has no published figure; it is the line we read the check against.